These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29649452)

  • 1. Serum secretory phospholipase A2 group IB correlates with the severity of membranous nephropathy.
    Li W; Zhang M; Guo Y; Liu X; Ji X; Su J; Zhang Z; Zhang F
    Clin Chim Acta; 2018 Jul; 482():178-184. PubMed ID: 29649452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sPLA2-IB Level Correlates with Hyperlipidemia and the Prognosis of Idiopathic Membranous Nephropathy.
    Yang LY; Wu YS; Dai BB; Lin SH; Chen H; Li GP; Tao X; Wan JX; Pan YB
    Curr Med Sci; 2020 Aug; 40(4):683-690. PubMed ID: 32862379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
    Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
    FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of serum anti-phospholipase A2 receptor antibody as a biomarker in membranous nephropathy: An experience from a tertiary care center of Eastern India.
    Mukherjee S; Kumar A; Maity P; Sengupta M; Basu K; Chaudhury AR; Bandopadhyay M; Chakraborty BC
    Indian J Pathol Microbiol; 2023; 66(2):269-277. PubMed ID: 37077067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy].
    DU YY; Jiang X; Wang WR; Tang XL; Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):579-584. PubMed ID: 36065689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.
    Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y
    Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
    Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
    Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
    Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
    PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
    PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of serum levels of anti-phospholipase A2 receptor antibodies in the diagnosis of primary membranous nephropathy.
    Ronchev Y; Terzieva D; Tilkiyan E
    Folia Med (Plovdiv); 2021 Oct; 63(5):692-696. PubMed ID: 35851203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary membranous nephropathy in adolescence: A prospective study.
    Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
    Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 receptor is associated with hypercoagulable status in membranous nephropathy: a narrative review.
    Lu X; Kan C; Zhang R
    Ann Transl Med; 2022 Sep; 10(17):938. PubMed ID: 36172093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.
    Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH
    Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis.
    Ong L; Silvestrini R; Chapman J; Fulcher DA; Lin MW
    Pathology; 2016 Apr; 48(3):242-6. PubMed ID: 27020499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis.
    Liang Y; Wan J; Chen Y; Pan Y
    BMC Nephrol; 2019 Sep; 20(1):360. PubMed ID: 31533641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.
    Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B
    Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.